Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Photoprotection by sunscreen depends on time spent on application

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Factors associated with cessation of sunbed use among Danish women

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Short-term chemical pretreatment cannot replace curettage in photodynamic therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The background and philosophy behind daylight photodynamic therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Organ transplant recipients express enhanced skin autofluorescence and pigmentation at skin cancer sites

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: If the recommended 1.0 mm layer of methyl aminolevulinate (MAL) is used during photodynamic therapy (PDT) of large areas with multiple actinic keratoses (AK) huge amounts of cream are needed.

OBJECTIVES: To report the amount of MAL used for PDT of AK and basal cell carcinomas (BCC) in daily routine. The association of protoporphyrin IX (PpIX) fluorescence and thickness of MAL was investigated in a randomized paired study in healthy volunteers.

METHODS: Amount of cream used per cm(2) during conventional and daylight PDT was recorded. In 16 healthy volunteers, 0.1 mm, 0.2 mm, 0.5 mm and 1.0 mm MAL cream were applied for 3 h on tape-stripped areas on each forearm randomized to light-permeable or light-impermeable occlusion. PpIX fluorescence was measured.

RESULTS: Less than 0.4 mm MAL was used during PDT of BCC and 0.2 mm for AK. No difference in PpIX fluorescence was found between the different thicknesses of MAL using light-impermeable occlusion.

CONCLUSION: In daily routine <0.4 mm MAL was used during PDT of BCC and 0.1-0.2 mm MAL during PDT of AK. The recommended 1.0 mm MAL did not result in a higher accumulation of PpIX compared to thinner MAL layers after light-impermeable occlusion for 3 h.

Original languageEnglish
JournalPhotodermatology, Photoimmunology & Photomedicine
Volume32
Issue number2
Pages (from-to)88-92
Number of pages5
ISSN0905-4383
DOIs
Publication statusPublished - Mar 2016

    Research areas

  • Adenocarcinoma, Aged, Aminolevulinic Acid, Female, Humans, Keratosis, Actinic, Male, Photochemotherapy, Skin Neoplasms, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

ID: 49585779